Single‐time‐point tumor dosimetry using population‐based model selection and nonlinear mixed‐effects modeling in [ <sup>177</sup> Lu]Lu‐PSMA‐617 therapy
Our findings demonstrate that a single SPECT/CT measurement at 3 days after injection may be used to estimate tumor TIAVs in [<sup>177</sup>Lu]Lu-PSMA-617 therapy using the NLME method and PBMS.
Authors
- Michael Mix (ORCID: https://orcid.org/0000-0002-9106-2519)
- Ade Riana
- Philipp T. Meyer (ORCID: https://orcid.org/0000-0001-8336-750X)
- Felix Kind (ORCID: https://orcid.org/0000-0002-9398-5747)
- U. Nemer
- Elham Yousefzadeh‐Nowshahr (ORCID: https://orcid.org/0000-0001-8675-9306)
- Indra Budiansah
- Ambros J. Beer (ORCID: https://orcid.org/0000-0001-9042-7806)
- Gerhard Glatting (ORCID: https://orcid.org/0000-0001-7916-1576)
- Deni Hardiansyah (ORCID: https://orcid.org/0000-0003-0984-8967)
Institutions
- Universität Ulm (DE)
- Stellenbosch University (ZA)
- University Medical Center Freiburg (DE)
- University of Indonesia (ID)
- Advanced Materials and Devices (United States) (US)
- University Hospital Ulm (DE)
- Technische Hochschule Ulm (DE)
Publication Details
- Journal
- Medical Physics
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1002/mp.70000
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00